Dysmenorrhea: The present views of etiopathogenesis and therapy in the practice of an obstetrician/gynecologist
- Authors: Dzhobava E.M.1, Loginova K.B.2
-
Affiliations:
- N.I. Pirogov National Research Medical University
- GBUZ DKC 1 MD
- Issue: No 11 (2014)
- Pages: 23-28
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247257
- ID: 247257
Cite item
Open Access
Access granted
Abstract
Dysmenorrhea is one of the most important problems not only from medical, but also social point of view. The paper describes the main forms of dysmenorrhea and the current concepts of its pathology and pathogenesis. It highlights the importance of pharmacotherapy as the key principle of treatment. The major drugs of choice for dysmenorrhea treatment and factors for its individualization are given in relation to the found features of the female body. The data of clinical trials of phosphodiesterase IV inhibitors are analyzed, which show the efficacy and safety of this drug group for the combination therapy of primary dysmenorrhea, particularly when the latter is concurrent with gastrointestinal and biliary abnormalities.
Full Text
About the authors
Eliso Murmanovna Dzhobava
N.I. Pirogov National Research Medical University
Email: lis9@rambler.ru
assistant of obstetrics and gynecology department, medical faculty № 2
Kermen Borisovna Loginova
GBUZ DKC 1 MD
Email: kermenl@yandex.ru
Phd, doctor consultant obstetrics-gynecologist; Department of Obstetrics and Gynecology RSMU.
References
- Прилепская В.Н. Дисменорея.Гинекология.2000; 1:34-9. [PrilepskayaV.N. Dysmenorrhea. Gynecology. 2000; 1: 34-9. In Russ.]
- Уварова Е.В. Нестероидные противовоспалительные препараты в комплексе лечебных и профилактических воздействий у больных с первичной и вторичной дисменореей. Русский медицинский журнал. 2005; 17: 1146-49. [Uvarova E.V. Nonsteroidal anti-inflammatory drugs in the complex of therapeutic and preventive effects in patients with primary and secondary dysmenorrhea. Russian Medical Journal. 2005; 17: 1146-49. In Russ.]
- Гуркин Ю.А. Гинекология подростков. Руководство для врачей. СПб.: Фолиант; 2000: 250-60. [Gurkin Yu.A. Gynecology of adolescents. Guide for physicians. SPb: Foliant; 2000: 250-60. In Russ.]
- Сасунова Р.А., Межевитинова Е.А. Современный взгляд на терапию первичной дисменореи. Гинекология. 2009; 11(1): 60-2. [Sasunova R.A., Mezhevitinova E.A. Modern view on the treatment of primary dysmenorrhea. Gynecology. 2009; 11 (1): 60-2. In Russ.]
- Тихомиров А.Л., Лубнин Д.М. Нурофен в лечение первичной дисменореи. Русский медицинский журнал. 2002; 7: 344-6. [Tikhomirov A.L., Lubnin D.M. Nurofen in the treatment of primary dysmenorrhea. Russian Medical Journal. 2002; 7: 344-6. In Russ.]
- King A.E., Critchley H.O., Kelly R.W. The NF-kappa B pathway in human endometrium and first trimester deciduas. Mol. Hum. Reprod. 2001; 7: 175-83.
- Sugino N., Karube-Harada A., Taketani T., Sakata A., Nakamura Y. Withdrawal of ovarian steroids stimulates prostaglandin F2α production through nuclear factor- kappa B activation via oxygen radicals in human endometrial stromal cells: potential relevance to menstruation. J. Reprod. Dev. 2004; 50(2): 215-25.
- Kelly R.W., King A.E., Critchley H.O. Cytokine control in human endometrium. Reproduction. 2001; 21(1): 3-19.
- Уварова Е.В., Гайнова И.Г. Применение линдинета в комплексе лечения девочек-подростков с дисменореей. Гинекология. 2005; 7(4): 206-9. [Uvarova E.V., Gainova I.G. Application of Lindinet in the complex treatment of adolescent girls with dysmenorrhea. Gynecology. 2005; 7 (4): 206-9. In Russ.]
- Debski R., Niemiec T., Mazurec M., Debska M. Comparative efficacy and tolerability of drotaverine 80 mg and ibuprofen 400 mg in patients with primary dysmenorrhea protocol DOROTA. Ginecol. Pol. 2007; 78: 933-8.
- Елизаветина Г.А., Минушкин О.Н. Рациональный подход к выбору спазмолитиков для купирования абдоминальной боли. Consilium medicum. 2011; 8: 57-60. [Elizavetina G.A., Minushkin O.N. A rational approach to the selection of antispasmodics for the relief of abdominal pain. Consilium medicum. 2011; 8: 57-60. In Russ.]
- Леонова М.В. Клиническая фармакология Но-шпа. Методическое пособие. М.; 2011. [Leonova M.V. Clinical pharmacology of No-shpa. Metodical Guideline. M.; 2011. In Russ.]
- Возовик А.В., Бажукова Н.Н. Дисменорея у подростков. Репродуктивное здоровье детей и подростков. 2008; 5: 40-2. [Vozovik A.V., Bazhukova N.N. Dysmenorrhea in adolescents. Reproductive health of children and adolescents. 2008; 5: 40-2. In Russ.]
- Уварова Е.В., Таточенко Н.М., Гайнова И.Г., Кудрякова Т.А. Лечение дисменореи у девушек препаратом Логест. Гинекология. 2001; 3(3): 99-101. [Uvarova E.V., Tatochenko N.M., Gainova I.G., Kudryakova T.A. Treatment of dysmenorrhea in women with Logest. Gynecology. 2001; 3 (3): 99-101. In Russ.]
Supplementary files
